Crym-expressing astrocytes in the striatum have been identified as key regulators of behaviors often seen in neuropsychiatric diseases, opening up new avenues for targeted therapies.
FDA+ roundup: Final guidance on the fastest oncology drug approvals; Remote inspections fail to take off
The FDA on Tuesday finalized guidance from July 2022 on the speedy cancer drug reviews that, for the last six years, the FDA’s Oncology Center
November 9, 2023